We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA Chip Technology Identifies Contributors to an Individual's Uniqueness

By LabMedica International staff writers
Posted on 16 Sep 2010
Building on an application that was developed in yeast four years ago, researchers scanned the human genome and identified what they believe is the basis for people to have such a wide diversity of physical traits and disease risks. More...


In a report published online August 2010 of the journal Cell, the scientists, from the Johns Hopkins University School of Medicine (Baltimore, MD, USA), identified a near complete catalog of the DNA segments that copy themselves, move around in, and insert themselves here and there in the genome. The insertion locations of these moveable segments-- transposons--in each individual's genome helps determine why some are tall or short, blond, or brunette, and more likely or less likely to have cancer or heart disease. The Johns Hopkins researchers reported that tracking the locations of transposons in individuals with specific diseases might lead to the finding of new disease genes or mutations.

Using their specialized "chip” with DNA spots that contain all of the DNA sequences that appear in the genome, researchers applied human DNA from 15 unrelated people. The research team compared transposon sites first identified in the original published human "index” genome and found approximately 100 new transposon sites in each person screened. "We were surprised by how many novel insertions we were able to find,” stated Jef Boeke, Ph.D., Sc.D., an author on the article, a professor of molecular biology and genetics, and codirector of the High Throughput Biology Center of the Institute for Basic Biomedical Sciences at Johns Hopkins. "A single microarray experiment was able to reveal such a large number of new insertions that no one had ever reported before. The discovery taught us that these transposons are much more active than we had guessed.”

Each of the 15 different DNA samples used in the research was purified from blood cells before it was applied to a DNA chip. Transposons adhere to areas on the DNA chip corresponding to where they are normally found in the genome, allowing the researchers locate new ones.

Dr. Boeke's group first invented the transposon chip in 2006 for use in yeast. However, it was Kathleen Burns, M.D., Ph.D., now an assistant professor of pathology at Johns Hopkins, who first got the chip to work with human DNA. "The human genome is much larger and more complex, and there are lots of look-a-like DNAs that are not actively moving but are similar to the transposons that we were interested in,” said Dr. Burns.

The hard part was to modify how they copied the DNA before it was applied over the chip. The researchers were able to copy DNA from the transposons of interest, which have just three different genetic code letters than other similar DNA segments.

"We've known that genomes aren't static places, but we didn't know how many transposons there are in each one of us; we didn't know how often a child is born with a new one that isn't found in either parent and we didn't know if these DNAs were moving around in diseases like cancer,” concluded Dr. Burns. "Now we have a tool for answering these questions. This adds a whole dimension to how we look at our DNA.”

Related Links:

Johns Hopkins University School of Medicine




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.